In 2021, a global tuberculosis vaccine research and development roadmap proposed a series of actions to accelerate the development of new, effective, and affordable vaccines that are urgently needed ...
A groundbreaking fridge‑free tetanus and diphtheria vaccine has taken a major step forward, following successful Phase 1 ...
India battles rabies: Stray dogs, missed vaccinations, and healthcare delays lead to multiple deaths
Rabies, a deadly but preventable disease, continues to claim lives across India, affecting people in villages, towns, and cities alike. Children playi.
HOCHTIEF has won a contract worth up to EUR 900 million to design and expand a 26-kilometer section of the East Link railway near Stockholm in partnership with Trafikverket. The OL31 Vagnhärad section ...
Practitioners nationwide are striving to do what’s best for children’s health, while staying supportive in the face of ...
ETVAX is the first vaccine that offers significant protection against pathogenic E. coli in children ...
Democrats didn't just experience a "blue wave" in November's off-year elections -- we saw a "blue tsunami." Across the country, Democrats won elections that many experts expected to be close -- from ...
The St. Mary's County government is saying goodbye to BoardDocs and hello to the Diligent platform for all meeting agendas, minutes and supporting materials. Visit ...
ILiAD Biotechnologies has closed an oversubscribed $115 million series B fundraise to support the company’s next-generation whooping cough vaccine candidate. Led by RA Capital Management, and with ...
WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today ...
Financing round led by RA Capital Management Proceeds to support Phase 3 development of BPZE1 with pivotal study to begin in 2026 ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results